Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial
This study will comply with the CONSORT guidelines. The projected s ample size requirement is 36 participants in a crossover trial giving a power of 80 % and a type-1 error rate of 0.05.DiscussionMIDAS seeks to enhance the quality of life in stroke survivors by assisting or resolving stroke-associated fatigue.Trial registrationACTRN12615000350527, registered on the 17 April 2015.Protocol version 3, approved 16 June 2015. (Source: Trials)
Source: Trials - August 16, 2016 Category: Research Source Type: clinical trials
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
Condition: Parkinson's Disease Interventions: Drug: Duloxetine; Drug: Donepezil; Drug: Modafinil Sponsor: University of Chicago Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials
Complementary Combination Therapy for Cocaine Dependence
Condition: Cocaine DependenceInterventions: Drug: Doxazosin; Drug: Modafinil; Drug: cocaine; Drug: PlaceboSponsor: Baylor College of MedicineRecruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2015 Category: Research Source Type: clinical trials
